Vigilant Biosciences Announces New Distribution Partnership Agreements for OncAlert™ Oral Cancer Product Line for Spain, Portugal and Germany November 14, 2016 FORT LAUDERDALE, Florida and DUSSELDORF, Germany Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, today announced exclusive multi-year distribution agreement for
Recent Comments